Protein kinase C inhibitors

Details Protein kinase C inhibitors Protein kinase C inhibitors

1996-10-21

1997-12-16

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

540545, A61K 3155, A61K 31395

Patent

active

056985789

ABSTRACT:
This invention provides novel bis-indolemaleimide macrocycle derivatives of the formula: ##STR1## The invention further provides the preparation, pharmaceutical formulations and the methods of use for inhibiting Protein Kinase C in mammals.

REFERENCES:
patent: 4785085 (1988-11-01), Kaneko et al.
patent: 4808613 (1989-02-01), Kaneko et al.
patent: 4923986 (1990-05-01), Murakata et al.
patent: 5043335 (1991-08-01), Kleinschroth et al.
patent: 5057614 (1991-10-01), Davis et al.
patent: 5292747 (1994-03-01), Davis et al.
patent: 5380746 (1995-01-01), Barth et al.
patent: 5438050 (1995-08-01), Kleinschroth et al.
patent: 5624949 (1997-04-01), Heath, Jr. et al.
Derwent Abstract 90-132947/18; 21.10.88-DE-835842.
Derwent Abstract 92-274042/33;90.11.20 90 JP-314628.
Meier, et al., Tetrahedron Letters, 34:33, 5277-5280 (1993).
Wilkinson, et al., Bichem. J., 294, 335-337 (1993).
Bit, et al., J. Med. Chem., 36, 21-29 (1993).
Martiny-Baron, et al., The Journal of Biological Chemistry, 268:13, 9194-9197 (1993).
Krakowiak, et al, SYNLETT, 611-620, (Sep. 1993).
Mulqueen, et al., Agents Actions, 37, 85-89 (1992).
Davis, et al., J. Med. Chem., 35, 177-184 (1992).
Davis, et al., J. Med. Chem., 35, 994-1001 (1992).
Toullec, et al., The Journal of Biological Chemistry, 266:24, 15771-15781 (1991).
Nixon, et al., Drugs Exptl. Clin. Res., 17:8, 389-393 (1991).
Davis, et al., Tetrahedron Letters, 31:36, 5201-5204 (1990).
Brenner, et al., Tetrahedron Letters, 44:10, 2887-2892 (1988).
Joyce, et al., The Journal of Organic Chemistry, 52:7, 1177-1186 (1987).
Buchdunger, et al., Proc. Natl. Acad. Sci. UDSA, 91, 2334-2338 (Mar. 1994).
Kobayashi, et al., The American Physiological Society, H1214-H1220 (1994).
Felsenstein, et al., Neuroscience Letters, 174 173-176 (1994).
Demaerschalck, et al., Biochimica et Biophysica Acta, 1181 214-218 (1993).
Shimohama, et al., Neurology, 43 1407-1413 (1993).
Fieser and Fieser, Reagents for Organic Synthesis, XII, John Wiley & Sons, p. 108 (1986).
Knaack, et al. "Clonal Insulinoma Cell Line that Stably Maintains Correct Glucose Responsiveness", Diabetes, vol. 43, 1413-17, Dec. 1994.
DeFronzo, R.A., "Diabetic Nephropathy: Etiologic and Therapeutic Considerations", Diabetes Reviews, vol. 3, No. 3, 510-564, 1995.
Inoguchi, et al., "Preferential Elevation of Protein Kinase C Isoform .beta.II and Diacylglycerol levels in the aorta and heart of diabetic rate; Differential reversibility to glycemic control by islet cell transplantation:", Proc. Natl. Acad. Sci. USA, vol. 89, 11059-11063, Nov. 1992.
Ishii, et al., "Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC .beta. Inhibitor:", Science, vol. 272, 728-731, 3 May 1996.
Porte, et al., "Diabetes Complications: Why is Glucose Potentially Toxic?", Science, vol. 272, 699-700, 3 May 1996.
Kowluru, et al., "Diabetes-Induced Disorders of Retinal Protein Kinase C and Na, K-ATPase are Inhibited by LY333531", Abstract, American Diabetes Association Meeting Jun. 8-11, 1996.
Ishii, et al., "Treatment with Protein Kinase C b Isoform Inhibitor Normalized Urinary Albumin Excretion and Glomerular Filtration Rate in Diabetic Rats", Abstract, American Diabetes Association Meeting, Jun. 8-11, 1996.
Koya, et al., "Normalization of Hyperglycemia-Induced Inhibition of Na.sup.+ -K.sup.+ ATPase Activity by Protein Kinase C (PKC) .beta.-Selective Inhibitor in Glomerular Mesangial Cells", Abstract, American Diabetes Association Meeting, Jun. 8-11, 1996.
Chen, et al., "Diacylglycerol-Protein Kinase C Signaling in Skeletal Muscle: A Possible Link to Insulin Resistance", Trans. Assoc. Am. Phys. 104: 206-12 (1991).
Wolf, et al., "Diacylglycerol Accumulation and Microvascular Abnormalities Induced by Elevated Glucose Levels", J. Clin. Invest., 87: 31-38 (1991).
Lee, et al., "Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications", Proc. Natl. Acad. Sci. USA, 86: 5141-5145.
Keen, H., "Chronic Complications of Diabetes Mellitus", Diabetes Mellitus, 9th Ed., Eli Lilly and Company, 1988.

Affiliated with

Also associated with

Rating

Protein kinase C inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein kinase C inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-206664